Scientists Announce Breakthrough in Producing Human Blood in the Lab
Scientists at the University of Cambridge have developed a novel method to produce human blood in the laboratory, potentially paving the way for treating leukemia and advancing stem cell transplants.
According to Zharfa News Agency, researchers used stem cells to create embryo-like structures called “hematoids” that mimic the natural blood production process in embryos. After two weeks of growth, these structures generate blood cells and even beating heart cells.
Hematoids, lacking vital tissues like the placenta, are valuable for studying leukemia and producing patient-compatible stem cells. Unlike previous methods, this approach simulates natural cell growth without requiring additional proteins.
Dr. Jitesh Neupane, the lead researcher, described the moment red blood appeared in the lab as “thrilling.” This model enhances understanding of early immune system development and disease modeling.
By day 13, hematoids produced red blood patches and can differentiate into various blood cells, including immune T-cells. This breakthrough marks a significant step toward personalized medicine and treating blood disorders.
